PROCEPT BioRobotics Corporation Common Stock

€17.65
EUR
Last updated on --.
24h volume1.76M
24h highest18.3942 EUR
24h lowest17.1050 EUR
24h Price movement+1.87%

PRCT recent prices

24 Hours
+1.87%+€0.32445
30 days
+1.26%+€0.2163
60 days
-29.29%-€7.186
90 days
-23.80%-€5.231

Key data

Previous close17.3300 EUR
Market cap992.55M EUR
Volume1.76M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.5487 EUR
Net income (FY)-88.66M EUR
Revenue (FY)278.62M EUR
Last report dateApr 30, 2026

About PROCEPT BioRobotics Corporation Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
HeadquartersSAN JOSE
Employees (FY)888.00
Revenue per employee (FY)313.76K EUR
Net income per employee (FY)-99.84K EUR
Listed onNasdaq
Official website

PRCT conversion tables

PRCTPRCT
EUREUR
0.5 PRCT8.827 EUR
1 PRCT17.65 EUR
5 PRCT88.27 EUR
10 PRCT176.54 EUR
EUREUR
PRCTPRCT
0.5 EUR0.028322 PRCT
1 EUR0.056643 PRCT
5 EUR0.28322 PRCT
10 EUR0.56643 PRCT

FAQ

PRCT is trading at €17.65, +1.87% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PRCT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PRCT is currently trading at €17.65, +1.87% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PRCT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PRCT's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PRCT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PRCT's historical range and other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
PROCEPT BioRobotics Corporation Common Stock's market cap is currently 992.55M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.76M
24h highest18.3942 EUR
24h lowest17.1050 EUR
24h Price movement+1.87%
PRCTPRCT
EUREUR
Start trade with PRCT Perpetual